Keros Therapeutics, Inc. (KROS)
Keros Therapeutics Market Cap: 584.64M for Jan. 9, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Eli Lilly & Co. | 952.28B |
| Pfizer Inc. | 144.81B |
| Innoviva, Inc. | 1.464B |
| Ocugen, Inc. | 466.92M |
| Bionano Genomics, Inc. | 16.03M |
Market Cap Related Metrics
| PE Ratio | 12.44 |
| PS Ratio | 3.162 |
| Price to Book Value | 0.8309 |
| Price to Free Cash Flow | 8.958 |
| Price | 19.19 |
| Earnings Yield | 8.04% |
| Operating PE Ratio | 17.90 |
| Normalized PE Ratio | 12.44 |